Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity
- Authors
- A Laio
- A Perez
- AD Becke
- AG Leslie
- AM Galea
- AM Maxam
- B Weigelt
- B Wu
- B Wu
- B Wu
- BC Behrens
- C Gossens
- C Hartwigsen
- C Scolaro
- C Scolaro
- CA Davey
- CS Allardyce
- DA Wolters
- EY Chua
- G Bussi
- G Sava
- GE Davey
- GE Davey
- J Tomasi
- J VandeVondele
- J VandeVondele
- JP Perdew
- L Kalé
- L Kelland
- L Soltes
- M Groessl
- M Rodriguez-Paredes
- M Sprik
- MQ Tran
- MS Ong
- O Novakova
- O Novakova
- P Banáš
- P Heffeter
- P Mehlen
- P Nowak-Sliwinska
- PC Mahalanobis
- PJ Hay
- RC Todd
- RE Aird
- RE Morris
- RH Shoemaker
- S Bailey
- S Goedecker
- S Joung
- S Tan
- SB Baylin
- SV Sharma
- T Laino
- U Essmann
- V Barone
- V Hornak
- WH Ang
- WL Jorgensen
- Y Jung
- Publication date
- 1 January 2014
- Publisher
- 'Springer Science and Business Media LLC'
- Doi
Abstract
10.1038/ncomms4462Nature Communications5Similar works
Available Versions
Last time updated on 09/02/2018
Last time updated on 25/04/2017